United States
Rithem Life Sciences is a manufacturing technology company with a mission to make life-saving medical equipment portable and accessible. Their flagship products, including the ResQR CPR aid and JoltzAED, aim to improve the effectiveness and timeliness of emergency medical care. The ResQR CPR aid is designed to enhance compression efficacy and address the common issues that lead to delayed or inadequate CPR. Meanwhile, the JoltzAED, set to launch in 1Q23, is positioned as "The AED Reimagined," offering unmatched portability and affordability without compromising professional-grade functionality. These innovative solutions align with the company's commitment to addressing gaps in emergency medical intervention.
Based in the United States, Rithem Life Sciences positions itself as a disruptive force in the medical technology space, leveraging advanced manufacturing processes to create groundbreaking products. Their dedication to making life-saving equipment more widely available underscores their commitment to societal impact and accessibility.
With a focus on redefining industry standards and leveraging cutting-edge technology, Rithem Life Sciences presents an enticing opportunity for venture capital investors seeking to support innovative solutions in the healthcare sector. As the company continues to expand its product portfolio and reach, it presents potential for significant growth and impact within the medical technology landscape.
